Your browser doesn't support javascript.
loading
Tolterodine ER reduced increased bladder wall thickness in women with overactive bladder. A randomized, placebo-controlled, double-blind, parallel group study.
Bray, Rhiannon; Cartwright, Rufus; Cardozo, Linda; Hill, Simon; Guan, Zhonghong; Khullar, Vik.
Afiliação
  • Bray R; Department of Urogynaecology, St Marys Hospital, Imperial NHS Trust, Paddington, London, UK.
  • Cartwright R; Department of Epidemiology and Biostatistics, Imperial College London, London, UK.
  • Cardozo L; Department of Urogynaecology, King's College Hospital, London, UK.
  • Hill S; Department of Obstetrics and Gynaecology, Queen's Park Hospital, Blackburn, UK.
  • Guan Z; Pfizer, Inc., New York, New York.
  • Khullar V; Department of Urogynaecology, St Marys Hospital, Imperial NHS Trust, Paddington, London, UK.
Neurourol Urodyn ; 37(1): 237-243, 2018 01.
Article em En | MEDLINE | ID: mdl-28407338

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Bexiga Urinária / Antagonistas Muscarínicos / Bexiga Urinária Hiperativa / Tartarato de Tolterodina Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Neurourol Urodyn Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Bexiga Urinária / Antagonistas Muscarínicos / Bexiga Urinária Hiperativa / Tartarato de Tolterodina Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Neurourol Urodyn Ano de publicação: 2018 Tipo de documento: Article